M. Ronner

Heterogeneity of RNA editing in mesothelioma and how RNA editing enzyme ADAR2 affects mesothelioma cell growth, response to chemotherapy and tumor microenvironment

H. Rehrauer, V. Serre-Beinier, W. Qi, 2022, bioRxiv.

Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma

H. Rehrauer, R. Stahel, Ferdinando Cerciello, 2022, JTO clinical and research reports.

Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition

Maxime Blijlevens, E. Smit, R. Stahel, 2019, Molecular Cancer Therapeutics.

miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery

W. Lam, R. Stahel, Ferdinando Cerciello, 2019, Non-coding RNA.

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma

R. Stahel, G. Reid, B. Schwaller, 2017, Front. Genet..

Hand2 delineates mesothelium progenitors and is reactivated in mesothelioma

Helena L. Crowell, M. Robinson, J. Huisken, 2020, Nature Communications.

Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development.

H. Rehrauer, Francesca Frontini, W. Qi, 2021, Cancer letters.

Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment

H. Rehrauer, V. Serre-Beinier, W. Qi, 2022, Molecular oncology.

Double-Stranded RNA Structural Elements Holding the Key to Translational Regulation in Cancer: The Case of Editing in RNA-Binding Motif Protein 8A

H. Rehrauer, W. Qi, Jelena Kresoja-Rakic, 2021, Cells.

A Novel BRCA1‐Associated Protein‐1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1‐Mediated DNA Repair

R. Stahel, L. Penengo, W. Weder, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Genome-wide silencing screen in mesothelioma cells reveals that loss of function of BAP1 induces chemoresistance to ribonucleotide reductase inhibition: implication for therapy

Maxime Blijlevens, E. Smit, R. Stahel, 2018, bioRxiv.